These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14707786)

  • 21. Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.
    Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN
    AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1149-56. PubMed ID: 19886839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No difference in in vitro susceptibility to HIV type 1 between high-risk HIV-negative Ethiopian commercial sex workers and low-risk control subjects.
    Messele T; Rinke de Wit TF; Brouwer M; Aklilu M; Birru T; Fontanet AL; Schuitemaker H; Hamann D
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):433-41. PubMed ID: 11282012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characterization of the CCR 5 gene in seronegative individuals exposed to human immunodeficiency virus (HIV).
    Rugeles MT; Solano F; Díaz FJ; Bedoya VI; Patiño PJ
    J Clin Virol; 2002 Jan; 23(3):161-9. PubMed ID: 11595595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA; Kang S; Koup RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.
    Agrawal L; Lu X; Qingwen J; VanHorn-Ali Z; Nicolescu IV; McDermott DH; Murphy PM; Alkhatib G
    J Virol; 2004 Mar; 78(5):2277-87. PubMed ID: 14963124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of HIV-1-specific T-cell immune responses in highly HIV-exposed uninfected individuals by in-vitro dendritic cell co-culture.
    Guardo AC; Ruiz-Riol M; Fernández E; Maleno MJ; Bargalló ME; León A; Climent N; García F; Gatell JM; Brander C; Plana M
    AIDS; 2015 Jul; 29(11):1309-18. PubMed ID: 26091301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects.
    Nicastri E; Sarmati L; Ercoli L; Mancino G; D'Ambrosio E; d'Ettorre G; Mastroianni CM; Vullo V; Andreoni M
    AIDS; 1999 Jul; 13(11):1333-6. PubMed ID: 10449285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of HIV-1 specific T lymphocyte responses in highly exposed persistently seronegative Chinese.
    Liu HW; Hong KX; Ma J; Yuan L; Liu S; Chen JP; Zhang YZ; Ruan YH; Xu JQ; Shao YM
    Chin Med J (Engl); 2006 Oct; 119(19):1616-21. PubMed ID: 17042974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
    Tiensiwakul P
    Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR5 expression and duration of high risk sexual activity among HIV-seronegative men who have sex with men.
    Thomas SM; Tse DB; Ketner DS; Rochford G; Meyer DA; Zade DD; Halkitis PN; Nádas A; Borkowsky W; Marmor M
    AIDS; 2006 Sep; 20(14):1879-83. PubMed ID: 16954729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.
    Sáez-Cirión A; Versmisse P; Truong LX; Chakrabarti LA; Carpentier W; Barré-Sinoussi F; Scott-Algara D; Pancino G
    Retrovirology; 2006 Nov; 3():81. PubMed ID: 17092330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia.
    Capoulade-Métay C; Ma L; Truong LX; Dudoit Y; Versmisse P; Nguyen NV; Nguyen M; Scott-Algara D; Barré-Sinoussi F; Debré P; Bismuth G; Pancino G; Theodorou I
    AIDS; 2004 Nov; 18(17):2243-52. PubMed ID: 15577536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project.
    Clerici M; Butto S; Lukwiya M; Saresella M; Declich S; Trabattoni D; Pastori C; Piconi S; Fracasso C; Fabiani M; Ferrante P; Rizzardini G; Lopalco L
    AIDS; 2000 Sep; 14(14):2083-92. PubMed ID: 11061648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assays.
    Keating SM; Bollinger RC; Quinn TC; Jackson JB; Carruth LM
    AIDS Res Hum Retroviruses; 2002 Sep; 18(14):1067-79. PubMed ID: 12396458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.
    Kaul R; Plummer FA; Kimani J; Dong T; Kiama P; Rostron T; Njagi E; MacDonald KS; Bwayo JJ; McMichael AJ; Rowland-Jones SL
    J Immunol; 2000 Feb; 164(3):1602-11. PubMed ID: 10640781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency of CCR5-delta32 homozygosity in HCV-infected, HIV-1-uninfected hemophiliacs results from resistance to HIV-1.
    Zhang M; Goedert JJ; O'Brien TR
    Gastroenterology; 2003 Mar; 124(3):867-8. PubMed ID: 12612937
    [No Abstract]   [Full Text] [Related]  

  • 37. Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons.
    Bernard NF; Yannakis CM; Lee JS; Tsoukas CM
    J Infect Dis; 1999 Mar; 179(3):538-47. PubMed ID: 9952359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.
    Paxton WA; Liu R; Kang S; Wu L; Gingeras TR; Landau NR; Mackay CR; Koup RA
    Virology; 1998 Apr; 244(1):66-73. PubMed ID: 9581779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission.
    Wasik TJ; Bratosiewicz J; Wierzbicki A; Whiteman VE; Rutstein RR; Starr SE; Douglas SD; Kaufman D; Sison AV; Polansky M; Lischner HW; Kozbor D
    J Immunol; 1999 Apr; 162(7):4355-64. PubMed ID: 10201969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.
    Ostrowski MA; Justement SJ; Catanzaro A; Hallahan CA; Ehler LA; Mizell SB; Kumar PN; Mican JA; Chun TW; Fauci AS
    J Immunol; 1998 Sep; 161(6):3195-201. PubMed ID: 9743388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.